General Neurology
Porphyria
Dec. 27, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
The patient was a 17-day-old boy whose symptoms included lethargy, fever, and right-sided clonic seizures. PCR for herpes simplex virus-2 was positive in the CSF and blood. The patient received high-dose parenteral acyclovir for 21 days, followed by oral acyclovir for 6 months. At follow-up, the patient had global developmental delay. MRI scans of the brain were obtained during the acute phase, on hospital day 2 (panels A-D), and during the chronic phase, at age 8 months (panels E and F). (A) Gadolinium administration reveals pial enhancement (arrow) in the left temporal-parietal region. (B) T1-weighted image reveals subtle focal hypointensity (arrow) in the region corresponding to the pial enhancement. (C) T2-weight image reveals focal hyperintensity (arrow) in the same region. (D) In the left temporal-parietal region, there is marked diffusion restriction (arrow). (E and F) Follow-up MRI scan at age 8 months reveals cystic encephalomalacia (arrows) in the same region in which abnormal signal was evident during the acute phase. (Contributed by Dr. Daniel Bonthius.)